Netsmart University Announces Partner Referral Agreement With New York Association of Alcohol and Substance Abuse Providers

... the New York State Association of Alcoholism and substance Abuse Providers (ASAP) for Netsmart University, ... the member association for the largest system of substance abuse providers in the nation. The agreement to ... the State of New York that provide alcoholism and substance abuse prevention, treatment, research and ...

Netsmart Technologies Selected by City and County of San Francisco to Provide Integrated Behavioral Healthcare Software System

... Citizens Using City and County Mental Health and substance Abuse Services GREAT RIVER, N.Y., Oct. 16 ... services to approximately 22,000 clients and substance abuse services to approximately 14,000 clients ... all modalities of mental health and substance abuse treatment, those clients receive almost two ...

Crime Labs Received an Estimated 2.7 Million Cases in 2005

... services, such as DNA analysis, controlled substance identification, and fingerprint examination. An ... than other forensic services, such as controlled substance identification. A typical DNA analyst completed ... in 2005. By comparison, the average controlled substance examiner completed about 10 times the number of ...

SynCo Bio Partners Completes Manufacture and Release of ActoGeniX' Lead Product for Phase II Clinical Trials

... manufacture and release of ActoGeniX' drug substance AG011 for use in a Phase II clinical trial with ... on a multi-agency project and deliver the drug substance on time is also an excellent example of project ... SynCo Bio Partners is a GMP-licensed bulk drug substance and final product CMO with in-depth clinical and ...

GRAS Status Opens Door to U.S. Food Industry

... (GRAS) is an FDA designation that a chemical or substance added to food is considered safe by experts, and ... procedures (or, in the case of a substance used in food prior to January 1, 1958, through ... under the conditions of their intended use. The substance must be shown to be "generally recognized" as ...

Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007

... non-GAAP measures to evaluate its business, the substance behind Boston Scientific management's decision to ... non-GAAP measures to evaluate its business, the substance behind Boston Scientific management's decision ... non-GAAP measures to evaluate its business, the substance behind Boston Scientific management's decision ...

Boston Scientific Announces Results for Third Quarter Ended September 30, 2007

... non-GAAP measures to evaluate its business, the substance behind Boston Scientific management's decision to ... non-GAAP measures to evaluate its business, the substance behind Boston Scientific management's decision to ... non-GAAP measures to evaluate its business, the substance behind Boston Scientific management's decision to ...

Netsmart Technologies Customer in Pennsylvania Recognized for Achieving Data Benchmarking Milestones

... of Pennsylvania's Office of Mental Health and substance Abuse Services, Department of Public Welfare. ... the highest quality of mental health and substance abuse treatment services to the citizens of the ... public health agencies, mental health and substance abuse clinics, psychiatric hospitals, and managed ...

R-Tech Ueno Notifies R&D Items

... diseases) The license is obtained from Astellas Pharma Inc. for the substance to inhibit the enzyme that increases in patients with diabetes mellitus. We intend to proceed with the development of this substance to be indicated for diabetic cataract, diabetic retinopathy and ...

Material world: Graphene's versatility promises new applications

... speculation that graphene could eventually supplant silicon as the substance of choice for computer chips, offering the prospect of ultrafast computers ... Center for Bioelectronics and Biosensors. As Tao explains, any biological substance that interacts with graphene's single atom surface layer can be detected, ...

Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference

... identity, purity, enzymatic activity, and potency of lots of L-DOS47 drug substance and drug product. The work presented demonstrates that analytical methods ... necessary quality control and stability testing programs for L-DOS47 drug substance and drug product lots. A copy of the poster is available on Helix's ...

Genomic Study Shows Organic Skin Care Product Activates Key Anti-Aging Gene

... activates Sirtuin-1, a key anti-aging gene. Until now only Resveratrol, a substance found in the skin of grapes and red wine, has been known to naturally ... activates Sirtuin-1, a key anti-aging gene. Until now only Resveratrol, a substance found in the skin of grapes and red wine, has been known to naturally ...

Researchers control the assembly of nanobristles into helical clusters

... The resulting capillary forcesthe wicking action or the ability of one substance to draw another substance into itcaused the individual strands to deform and to adhere to one ...

CAS Registers 40 Millionth Substance in CAS REGISTRY(SM)

... REGISTRY, the world's most authoritative collection of disclosed chemical substance information, now includes 40 million organic and inorganic substances. CAS ... ) The 40 millionth substance was identified by a team of CAS scientists, C.H. Oh, J.H. Lee, S.J. Lee, ....

ev3 Inc. Reports Third Quarter 2008 Financial Results

... these non-GAAP measures to conduct and evaluate its business, the economic substance behind management's decision to use these non-GAAP measures, the ... 105,000,000 105,000,000 105,000,000 105,000,000 "Use and Economic substance of Non-GAAP Financial Measures Used by ev3 and Usefulness of Such Non-GAAP ...

Digesting the termite digestome -- a way to make biofuels?

... are far less accessible. This is because they're locked up within a substance known as lignocellulose, which provides structural support for plant cell walls. Breaking this substance up into its component sugar molecules is far from easy. One approach ...

White Paper Explains Aspects of Testing From Purified Bulk Drug Substance to Sterile Liquid Final Drug Product

... drug product's manufacturing life cycle: going from the purified bulk drug substance ("PBDS") to the sterile final drug product ("FDP"). It is available for ... download the white paper, "Where and What to Test: From Purified Bulk Drug substance to Sterile Liquid Final Drug Product," visit: ...

Helix BioPharma product development update, quarterly highlights and financial results for fiscal Q3 2008

... further scale-up the GMP production of the L-DOS47 active drug substance for purposes of producing clinical trial batches. Investor and Media ... BioVectra dcl to further advance GMP production of the L-DOS47 active drug substance to a scale that is suitable for human clinical testing. In addition, ...

Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update

... of biomarkers for platinum resistance. * Picoplatin Drug substance Manufacturing: We announced an agreement with W. C. Heraeus GmbH for the manufacture and supply of picoplatin drug substance to support our clinical trials and commercial product needs. ...

Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions

... human services organizations, public health departments, mental health and substance abuse clinics, psychiatric hospitals, vital records offices and managed ... (CCHIT), Netsmart became the first behavioral healthcare, public health, substance abuse and methadone software and services provider to have a product ...

Highlands Behavioral Health Hospital Unveils New Substance Abuse Detox Program

... Customized program offers substance abuse treatment for teens and adults HIGHLANDS RANCH, Colo., Dec. 19 ... to an increase in demand for substance abuse services. "We find that substance abuse is a major factor in the majority of teen suicides," said Morris. ...

Dark energy -- 10 years on

... of our universe is made up of some weird, gravitationally repulsive substance that was only discovered ten years ago dark energy. This month in ... universe is made up of dark energy, 21 per cent of dark matter, another substance we know little about, with only a remaining four per cent being made up of ...

ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information

... is an analog of the naturally occurring human neuropeptide substance P, which can be found throughout the body, including in the airways of ... multiple homeland security bioterrorism threats. Homspera is derived from substance P, a naturally occurring peptide immunomodulator and homeostatic compound ...

Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results

... Laboratory an exclusive worldwide license for nine patents in the United States relating to the right to use vigabatrin to treat a wide variety of substance addictions and obsessive-compulsive disorders. Catalyst has also been granted rights to Brookhaven's vigabatrin-related foreign patents or patents ...

BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing

... reaction with the steel wool, including at least one of the following events: color change in the solution, precipitation of an undetermined substance from the solution, disintegration of the steel wool into filings, deposition on the steel wool, dissolution of the steel wool, effervescence from the ...

SynCo Bio Partners Increases its Capacities by Expanding its Quality Team

... please visit http://www.syncobiopartners.com About SynCo Bio Partners B.V. SynCo Bio Partners is a GMP-licensed bulk drug substance and final product CMO with clinical and commercial production experience with mammalian and microbial systems. This experience has been acquired by ...

Remuda Ranch Programs for Eating and Anxiety Disorders Reports Need for Increasing Awareness of Eating Disorders in Males

... acquired. Each boy has a team of professionals, who not only treat the eating disorder, but address co-occurring issues such as depression, anxiety, substance abuse and trauma. Since 1990, Remuda has provided care to nearly 9,000 patients with eating disorders. Ninety-five percent of Remuda's patients ...

Stanford researchers find a quicker, cheaper way to sort isotopes

... part of the world around you carries special chemical markers. These markers, called isotopes, can tell scientists where the molecules that compose a substance are from, where they traveled, and what happened to them along the way. But doing these analyses has been complex and costly. Now, Stanford chemists ...

Advanced Life Sciences' Restanza(TM) Shows 100% Survival In Confirmatory Anthrax Study

... studies in humans cannot be ethically conducted because the studies would involve administering a potentially lethal or permanently disabling toxic substance or organism to healthy human volunteers. Approval of a drug under the "Animal Efficacy Rule" is subject to certain post-approval commitments, ...

AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule

... Cetrorelix is part of AEterna Zentaris' luteinizing hormone-releasing hormone (LHRH) antagonist therapeutic approach. This peptide-based active substance was developed by the Company in cooperation with Nobel Prize winner Prof. Andrew Schally, currently of the U.S. Veterans Administration in Miami. ...

AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia

... Cetrorelix is part of AEterna Zentaris' luteinizing hormone-releasing hormone (LHRH) antagonist therapeutic approach. This peptide-based active substance was developed by the Company in cooperation with Nobel Prize winner Prof. Andrew Schally, currently of the U.S. Veterans Administration in Miami. ...

TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford

... to include an annual international conference, TEDGlobal; media initiatives, including TEDTalks and TED.com; and the TED Prize. TEDGlobal 2009, "The substance of Things Not Seen," will be held July 21-24, 2009, in Oxford, UK. TEDIndia will be held in Mysore, India, Nov. 1-4, 2009. TED2010, "What the World ...

Catalyst Pharmaceutical Partners Receives NASDAQ Deficiency Notice

... Laboratory an exclusive worldwide license for nine patents in the United States relating to the right to use vigabatrin to treat a wide variety of substance addictions and obsessive-compulsive disorders. Catalyst has also been granted rights to Brookhaven's vigabatrin-related foreign patents or patents ...

NeurogesX Receives European Commission Approval for Qutenza(TM)

... for Human Use (CHMP) on March 19, 2009. Qutenza, a cutaneous (dermal) patch, is designed to locally deliver a high-concentration (8%) of the active substance capsaicin and to provide sustained relief from peripheral neuropathic pain. Following application to the painful areas on the skin, Qutenza is ...

Scientists demonstrate effect of confining dielectrics on semiconductor nanowire conductivity

... the phenomenon has implications for improving the design of semiconductor nanowires as electronic devices, such as in the case of gas or liquid substance detectors. "The demonstrated effect sets in as circuit dimensions shrink, which makes the material more sensitive to external conditions," ...

SynCo Bio Partners Wins Best Contract Manufacturing Organization 2009 ViE Award

... by De Facto Communications For more information, contact: About SynCo Bio Partners B.V. SynCo Bio Partners is a GMP-licensed bulk drug substance and final product CMO with in-depth clinical and commercial production experience with mammalian and microbial systems. This experience has been ...

Bavarian Nordic Publishes its Annual Results 2008

... reasons, dismissed the first complaint. If the court eventually should decide to dismiss the suit this decision will bear no influence on the substance of the patent case. It only influences the timing of the start of the infringement case. Changes in management Executive Vice ...

Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results

... Laboratory an exclusive worldwide license for nine patents in the United States relating to the right to use vigabatrin to treat a wide variety of substance addictions. Catalyst has also been granted rights to Brookhaven's vigabatrin-related foreign patents or patents pending in more than 30 countries. ...

RoundTable Healthcare Partners Facilitates Product Acquisition for CorePharma

... CorePharma's diversified product portfolio consists of solid-dose tablets and capsules, and includes modified release dosage form and controlled substance products. The Company's products serve a variety of therapeutic areas and are sold largely through retail channels in the U.S. market. RoundTable ...

Kibow Biotech Strongly Supports World Kidney Day for Maintenance of Healthy Kidney Function

... lead product, Kibow Biotics(R) has its own self-acclaimed US FDA GRAS status. GRAS is an acronym for Generally Recognized As Safe and means that the substance is generally recognized, among qualified scientific and medical experts, as having been adequately shown to be safe under the conditions of its ...